Che, Y., Zeng, R., Tang, D., Bai, O., Jia, Y., Gao, Y., Yan, X., Ding, X., Sun, X., Wang, X., Xu, B., Wang, H., Qu, D., Xu, L., Li, N., Zhang, Q., Zhou, H., Sun, X. (2025). Real-world, multicenter study of brentuximab vedotin-based regimens in Chinese patients with relapsed/refractory Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood-2025-7142